These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2246324)

  • 1. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2.
    Cutts JL; Bankhurst AD
    J Cell Physiol; 1990 Nov; 145(2):244-52. PubMed ID: 2246324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of mevalonic acid in the regulation of natural killer cell cytotoxicity.
    Cutts JL; Scallen TJ; Watson J; Bankhurst AD
    J Cell Physiol; 1989 Jun; 139(3):550-7. PubMed ID: 2738100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis.
    Tanaka T; Porter CM; Horvath-Arcidiacono JA; Bloom ET
    Int Immunol; 2007 Feb; 19(2):163-73. PubMed ID: 17182966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interleukin 2 enhanced natural killer cell-mediated cytotoxicity in human lymphocyte subpopulations expressing the Leu 7 and Leu 11 antigens.
    Lanier LL; Benike CJ; Phillips JH; Engleman EG
    J Immunol; 1985 Feb; 134(2):794-801. PubMed ID: 3871216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human natural killer cell activity by the protein kinase C inhibitor 1-(5-isoquinolinesulfonyl)-2-methylpiperazine is an early but post-binding event.
    Steele TA; Brahmi Z
    J Immunol; 1988 Nov; 141(9):3164-9. PubMed ID: 3262683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of human natural killer cell activity by platelet-derived growth factor. II. Membrane binding studies, effects of recombinant IFN-alpha and IL-2, and lack of effect on T cell and antibody-dependent cellular cytotoxicity.
    Gersuk GM; Chang WC; Pattengale PK
    J Immunol; 1988 Dec; 141(11):4031-8. PubMed ID: 2846698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals.
    Robertson MJ; Cameron C; Lazo S; Cochran KJ; Voss SD; Ritz J
    Nat Immun; 1996-1997; 15(5):213-26. PubMed ID: 9390270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K; Varalakshmi C; Khar A
    Cytokines Cell Mol Ther; 1997 Mar; 3(1):51-8. PubMed ID: 9287244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lovastatin inhibits proliferation of rat mesangial cells.
    O'Donnell MP; Kasiske BL; Kim Y; Atluru D; Keane WF
    J Clin Invest; 1993 Jan; 91(1):83-7. PubMed ID: 8423236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of neuroblastoma cells induced by an inhibitor of mevalonate synthesis: relation of neurite outgrowth and acetylcholinesterase activity to changes in cell proliferation and blocked isoprenoid synthesis.
    Maltese WA; Sheridan KM
    J Cell Physiol; 1985 Dec; 125(3):540-58. PubMed ID: 3851809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-2 can induce suppression of human natural killer cell cytotoxicity.
    Hellstrand K; Hermodsson S
    Clin Exp Immunol; 1989 Sep; 77(3):410-6. PubMed ID: 2509116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lovastatin-induced proliferation inhibition and apoptosis in C6 glial cells.
    Choi JW; Jung SE
    J Pharmacol Exp Ther; 1999 Apr; 289(1):572-9. PubMed ID: 10087052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natural killer and lymphokine-activated killer cell activities from human marrow precursors. II. The effects of IL-3 and IL-4.
    Keever CA; Pekle K; Gazzola MV; Collins NH; Bourhis JH; Gillio A
    J Immunol; 1989 Nov; 143(10):3241-9. PubMed ID: 2809200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of human natural killer cell migration and proliferation by the exodus subfamily of CC chemokines.
    Robertson MJ; Williams BT; Christopherson K; Brahmi Z; Hromas R
    Cell Immunol; 2000 Jan; 199(1):8-14. PubMed ID: 10675270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-7 selectively enhances natural kill cytotoxicity mediated by the CD56bright natural killer subpopulation.
    Dadmarz R; Bockstoce DC; Golub SH
    Lymphokine Cytokine Res; 1994 Dec; 13(6):349-57. PubMed ID: 7535569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins inhibit NK-cell cytotoxicity by interfering with LFA-1-mediated conjugate formation.
    Raemer PC; Kohl K; Watzl C
    Eur J Immunol; 2009 Jun; 39(6):1456-65. PubMed ID: 19424968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of IL-4 on human natural killer cells. A potent regulator of IL-2 activation and proliferation.
    Nagler A; Lanier LL; Phillips JH
    J Immunol; 1988 Oct; 141(7):2349-51. PubMed ID: 3262658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interferons or interleukin-2 increase cytotoxicity by human monocytes and NK cells.
    Frey JR; Kamber M; Peck R
    Lymphokine Res; 1987; 6(3):215-27. PubMed ID: 3114569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.